Home > Boards > US Listed > Biotechs > XOMA Corporation (XOMA)

Presentation at Credit-Suisse-Healthcare-Conference was interesting.. cc transcript here

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
ECole Member Profile
 
Followed By 20
Posts 1,363
Boards Moderated 1
Alias Born 07/02/13
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 5:07:34 PM
XOMA EPS beats by $0.03, misses on revenue Seeking Alpha - 8/5/2021 8:49:53 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 8/5/2021 8:07:06 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/5/2021 7:43:26 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/5/2021 7:36:13 AM
XOMA Reports Second Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire Inc. - 8/5/2021 7:30:00 AM
XOMA Gets Orphan Drug Designation for Pancreatic Cancer Treatment Dow Jones News - 7/28/2021 9:47:00 AM
FDA grants orphan drug status to XOMA's pancreatic cancer treatment NIS793 Seeking Alpha - 7/28/2021 8:26:18 AM
U.S. Food and Drug Administration has Granted Orphan Drug Designation to XOMA’s Licensed anti-TGFβ Asset NIS793 GlobeNewswire Inc. - 7/28/2021 7:30:00 AM
XOMA Acquires Royalty and Milestone Interest in Checkmate’s Vidutolimod (CMP-001) from Kuros Biosciences GlobeNewswire Inc. - 7/15/2021 4:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 5:09:56 PM
XOMA Declares Quarterly Preferred Stock Dividends GlobeNewswire Inc. - 6/21/2021 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2021 4:31:32 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2021 4:31:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2021 4:31:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2021 4:31:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/21/2021 4:30:55 PM
XOMA Licensees to Present Significant Clinical Data at 2021 ASCO Annual Meeting GlobeNewswire Inc. - 5/21/2021 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/20/2021 5:02:42 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/6/2021 8:36:10 AM
XOMA EPS misses by $0.55, misses on revenue Seeking Alpha - 5/6/2021 7:57:32 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/6/2021 7:46:38 AM
XOMA Reports First Quarter 2021 Financial Results and Highlights Recent Operational Events GlobeNewswire Inc. - 5/6/2021 7:30:00 AM
XOMA Earns Milestone for First Patient Dosed in Phase 3 Development Program Dow Jones News - 5/3/2021 8:32:00 AM
XOMA gets milestone payment from Janssen Biotech Seeking Alpha - 5/3/2021 7:43:03 AM
ECole   Friday, 11/29/13 06:44:49 AM
Re: None
Post # of 5639 
Presentation at Credit-Suisse-Healthcare-Conference was interesting.. cc transcript here


http://www.earningsimpact.com/Transcript/84698/XOMA/XOMA-Corporation---2013-Credit-Suisse-Healthcare-Conference

I record my personal, subjective observations about the markets, solely for my entertainment and that of interested readers and to foster research. Nothing should be construed as financial advice or an offer or recommendation to purchase or sell any secur
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences